A purity figure is the first number most people read on a research peptide label, and often the only one they remember. It is also one of the least self-explanatory. On a small UK biotech bench, where a single vial may underpin weeks of assay work, treating a percentage as a complete statement of quality is a quiet route to wasted time, ambiguous results and awkward conversations at the bench review. Identity testing is not a premium extra bolted onto a purity result; it is the second half of the same question.
What a Purity Percentage Actually Measures — and What It Cannot
On a typical certificate of analysis, purity is expressed as a percentage derived from high-performance liquid chromatography with ultraviolet detection. The software integrates the peaks in the chromatogram, takes the area of the principal peak and reports it as a proportion of total integrated area. That is a statement about the relative abundance of UV-absorbing material under one defined method: a particular column, mobile phase gradient, wavelength, injection volume and integration threshold. Change any of those parameters and the number moves. Purity is therefore a method-dependent, comparative measurement, not an absolute property of the vial.
What the figure never does on its own is confirm that the dominant peak is the molecule you ordered. A truncated sequence, a deamidated variant, a diastereomer or a close structural analogue can elute within a fraction of the target retention time and be counted as product. In that scenario a sample may be reported at ≥99% purity and still be the wrong compound, or the right compound carrying a co-eluting impurity the method cannot resolve. The percentage answers “how much of the main thing is there?” It does not answer “what is the main thing?”
This is precisely why identity testing has to sit beside purity rather than beneath it. Identity is established by methods working on a different physical basis: mass spectrometry to confirm molecular mass, tandem MS or sequence analysis for sequence information, amino acid analysis, or retention matching against a verified reference standard. Orthogonal methods are the entire point. A technique that separates on the same principle as the original HPLC run is unlikely to expose the same blind spot. A mass confirmation returning the expected value tells you something no area percentage can.
Contaminant screening then forms a third, separate axis. Heavy-metal evaluation and endotoxin screening, as described in the supplier’s published testing framework, are neither purity nor identity — they are questions about what else is present. Research Sciences lists batch-level analytical verification supporting purity, identity and contaminant screening on its homepage, alongside headline lines such as “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity”. Treat those as the shop’s published figures at the time of reading, and reconfirm the exact value both on the live site and, more importantly, on the CoA that accompanies your specific batch.
Where Identity Evidence Lives: CoAs, ITRs and the Fine Print
Identity evidence lives in documents as much as in chromatograms. The Research Sciences FAQ states that a certificate of analysis is provided for every product, covering HPLC purity and identity, with compounds produced by international partners using solid-phase peptide synthesis, independently tested and then subject to final verification and quality checks in the UK before release. That final in-country check matters for a small bench: it is the last point at which documentation and physical stock are reconciled before dispatch.
Read the CoA as a matched pair of results, not a single headline. Check the identity method and its stated outcome next to the purity method and its outcome, then check the batch reference on the vial label against the certificate. Labels follow a SKU-plus-expiry format — BPC10-03/27 is the example the shop gives — and that reference is the one to quote in any correspondence about documentation. If the reference is missing, damaged or illegible, the identity link between paperwork and vial is broken regardless of how good the purity figure looks.
Two procedural details catch people out. First, the FAQ notes that restocked products may carry the same Internal Test Reference as earlier stock: an ITR links to associated sample testing reports, but it does not confirm that separate deliveries came from the same production lot or were separately independently tested. A familiar ITR is not a substitute for reading the current batch document. Second, vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Neither is the visual appearance of a lyophilised cake. Kit appearance is not data.
Worth knowing, too, that the FAQ states all peptides contain trace amounts of mannitol as an excipient — present for stability during lyophilisation, solubility and protection in storage. It is part of the formulation, not an analyte of interest, and it should be accounted for when interpreting any chromatographic result. The shop also does not supply blended peptides, recommending single compounds combined only within a controlled experimental design; from an identity standpoint, single-vial materials are simply easier to trace, because one reference maps to one labelled compound.
Building an Identity-First Routine on a Small Bench
Documentation before dispensing
Log the batch reference and expiry on receipt, file the CoA against that same reference, and cross-check the two before the vial enters the freezer. A single register covering compound, reference, date received, CoA location and storage location costs very little and makes an audit trail possible months later. When a query arises, quoting the reference gets a faster, more accurate answer than describing the vial from memory.
Handling inside an in-vitro workflow
Allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required for the experiment. Store lyophilised material at −20°C or below, sealed with desiccant and protected from moisture, heat and light; avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use. Diluent volume and final concentration should be calculated for the in-vitro assay in front of you — the free reconstitution calculator on the product pages is a laboratory tool only. All materials are research-use only and are not for human or veterinary use, and the calculator must never be used for dosing.
Questions worth putting to a supplier
For the UK research materials listed by Uk peptides, the FAQ states that every compound is supplied with a CoA covering HPLC purity and identity, and the homepage notes that listings reference “CoAs Janoshik Analytical Reports” — so open the certificate for your own batch rather than relying on the site wording. Ask which identity method was used, whether the reference on your vial matches the certificate, and how the material is held in transit; Research Sciences describes temperature-aware storage and tracked domestic fulfilment, dispatching orders the next working day via Royal Mail Tracked 24, which is an estimate rather than a guarantee, and the homepage “24hr UK Delivery” line should likewise be reconfirmed at checkout. Payment is by bank transfer through Open Banking providers rather than card, and returns are not accepted once dispatched, with refunds only for damage, incorrect supply or quality issues under the published policy.
None of that documentation replaces a local decision about suitability. The purchaser remains responsible for lawful use, safe handling, storage and disposal, and for compliance with COSHH and laboratory safety standards. Materials are not for human or veterinary use, and identity testing on paper is only ever as good as the habit of checking it against the vial in your hand.